Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Double Cord Versus Haploidentical (BMT CTN 1101)
- Status
- COMPLETED
- Phase
- PHASE3
Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
- Status
- TERMINATED
- Phase
- PHASE2
Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Velcade, Nipent, Rituxan (VNR) in Subjects With Relapsed Follicular, Marginal Zone, and Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Mantle Cell Lymphoma Treatment by RiBVD
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL
- Status
- UNKNOWN
- Phase
- PHASE3
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
- Status
- UNKNOWN
- Phase
- PHASE1
Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2